Topics Related to Physicians, Physician Assistants and Nurse Practitioners
As of April 1, 2023, all NC Health Choice beneficiaries with active eligibility will be moved to Medicaid.
Effective Dec. 7, 2022, Medicaid and NC Health Choice cover bendamustine hydrochloride injection, for intravenous use (Vivimusta).
Effective Jan. 9, 2023, Medicaid and NC Health Choice cover mosunetuzumab-axgb injection, for intravenous use (Lunsumio).
Effective Dec. 1, 2022, Medicaid and NC Health Choice cover teplizumab-mzwv injection.
Effective Nov. 16, 2022, Medicaid and NC Health Choice cover tremelimumab-actl injection.
Effective Dec. 15, 2022, Medicaid and NC Health Choice cover mirvetuximab soravtansine-gynx injection.
Note: This bulletin is replaced by NC Health Choice Move to Medicaid: Timeline for Claims Adjudication and Process for Prior Approvals.
Effective with date of service Nov. 15, 2022, Medicaid and NC Health Choice cover Eflapegrastim-xnst injection, for subcutaneous use (Rolvedon).
Effective with date of service Oct. 19, 2022, Medicaid and NC Health Choice cover Sodium Thiosulfate injection, for intravenous use (Pedmark).
Effective with date of service Oct. 3, 2022, Medicaid and NC Health Choice cover Ranibizumab-eqrn injection, (Cimerli)